Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Deoxycytidine
  • Pancreatic Neoplasms
  • Radiosurgery

abstract

  • Fractionated SBRT with GEM results in minimal acute and late gastrointestinal toxicity. Future studies should incorporate SBRT with more aggressive multiagent chemotherapy.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4368473

Digital Object Identifier (DOI)

  • 10.1002/cncr.29161

PubMed ID

  • 25538019

Additional Document Info

start page

  • 1128

end page

  • 37

volume

  • 121

number

  • 7